$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

$foxo Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024004925 Filed on January 19, 2024

Income Statement

Concept	2024 Q1	2023 Q3
Revenue	$7.000K	$10.00K
YoY Change	-46.15%	-28.57%
Cost Of Revenue		$70.00K
YoY Change		400.0%
Gross Profit		-$60.00K
YoY Change
Gross Profit Margin		-600.0%
Selling, General & Admin	$988.0K	$4.717M
YoY Change	-84.4%	-42.96%
% of Gross Profit
Research & Development	$165.0K	$283.0K
YoY Change	-46.6%	-49.28%
% of Gross Profit
Depreciation & Amortization	$260.0K	$75.00K
YoY Change	-72.01%	7.14%
% of Gross Profit
Operating Expenses	$1.186M	$3.447M
YoY Change	-83.98%	-60.95%
Operating Profit	-$1.179M	-$3.507M
YoY Change	-84.05%	-60.21%
Interest Expense	$42.00K	$148.0K
YoY Change	-81.33%	-65.09%
% of Operating Profit
Other Income/Expense, Net	-$325.0K	-$41.00K
YoY Change	-115.62%	-94.74%
Pretax Income	-$1.504M	-$3.660M
YoY Change	-80.31%	-91.08%
Income Tax
% Of Pretax Income
Net Earnings	-$1.504M	-$3.660M
YoY Change	-80.31%	-91.08%
Net Earnings / Revenue	-21485.71%	-36600.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.24	-$0.75
COMMON SHARES
Basic Shares Outstanding	8.946M shares	51.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.000K	$42.00K
YoY Change	-99.86%	-99.6%
Cash & Equivalents	$3.000K	$42.00K
Short-Term Investments
Other Short-Term Assets	$104.0K	$106.0K
YoY Change	-2.8%	430.0%
Inventory		$1.131M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$262.0K	$2.585M
YoY Change	-95.83%	-85.48%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$2.621M
YoY Change	40.69%
Long-Term Investments
YoY Change
Other Assets	$111.0K	$118.0K
YoY Change	-93.58%	-99.5%
Total Long-Term Assets	$2.732M	$546.0K
YoY Change	-24.05%	-98.98%
TOTAL ASSETS
Total Short-Term Assets	$262.0K	$2.585M
Total Long-Term Assets	$2.732M	$546.0K
Total Assets	$2.994M	$3.131M
YoY Change	-69.67%	-95.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.988M	$4.816M
YoY Change	67.55%	77.97%
Accrued Expenses	$1.815M	$1.528M
YoY Change	49.75%	205.6%
Deferred Revenue
YoY Change
Short-Term Debt	$386.0K	$0.00
YoY Change
Long-Term Debt Due	$4.461M	$4.006M
YoY Change	32.37%
Total Short-Term Liabilities	$17.07M	$13.52M
YoY Change	98.86%	-59.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$859.0K	$718.0K
YoY Change	-34.92%	-96.59%
Total Long-Term Liabilities	$859.0K	$718.0K
YoY Change	-34.92%	-97.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.07M	$13.52M
Total Long-Term Liabilities	$859.0K	$718.0K
Total Liabilities	$17.93M	$14.23M
YoY Change	81.07%	-74.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$179.2M	-$172.3M
YoY Change	15.72%	33.65%
Common Stock	$1.000K	$6.000K
YoY Change		100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$14.94M	-$11.10M
YoY Change
Total Liabilities & Shareholders Equity	$2.994M	$3.131M
YoY Change	-69.67%	-95.62%

Cashflow Statement

Concept	2024 Q1	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.504M	-$3.660M
YoY Change	-80.31%	-91.08%
Depreciation, Depletion And Amortization	$260.0K	$75.00K
YoY Change	-72.01%	7.14%
Cash From Operating Activities	$1.716M	-$865.0K
YoY Change	-151.07%	-79.74%
INVESTING ACTIVITIES
Capital Expenditures	$2.122M	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$2.122M	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$371.0K	692.0K
YoY Change		-120.97%
NET CHANGE
Cash From Operating Activities	$1.716M	-865.0K
Cash From Investing Activities	-$2.122M	0.000
Cash From Financing Activities	$371.0K	692.0K
Net Change In Cash	-$35.00K	-173.0K
YoY Change	-98.96%	-97.85%
FREE CASH FLOW
Cash From Operating Activities	$1.716M	-$865.0K
Capital Expenditures	$2.122M	$0.00
Free Cash Flow	-$406.0K	-$865.0K
YoY Change	-87.92%	-81.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
	foxo	Management Contingent Share Plans ManagementContingentSharePlans		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39783
	dei	Entity Registrant Name EntityRegistrantName	FOXO TECHNOLOGIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1050265
	dei	Entity Address Address Line1 EntityAddressAddressLine1	729 N
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Washington Ave
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
	dei	City Area Code CityAreaCode	(612)
	dei	Local Phone Number LocalPhoneNumber	562-9447
	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	FOXO
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8946032	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5515000	usd
CY2023Q3	us-gaap	Supplies Supplies	1131000	usd
CY2022Q4	us-gaap	Supplies Supplies	1313000	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1306000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2686000	usd
CY2022Q4	foxo	Prepaid Consulting Fees PrepaidConsultingFees	2676000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	106000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	114000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2585000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12304000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	428000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2043000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	18573000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2225000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	118000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	263000	usd
CY2023Q3	us-gaap	Assets Assets	3131000	usd
CY2022Q4	us-gaap	Assets Assets	35408000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4816000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3466000	usd
CY2023Q3	foxo	Senior Paid In Kind Notes SeniorPaidInKindNotes	4006000	usd
CY2022Q4	foxo	Senior Paid In Kind Notes SeniorPaidInKindNotes	1409000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1528000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1045000	usd
CY2023Q3	foxo	Accrued Settlement AccruedSettlement	2300000	usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	119000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	493000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13516000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6913000	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	67000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	311000	usd
CY2022Q4	foxo	Senior Paid In Kind Notes Non Current SeniorPaidInKindNotesNonCurrent	1730000	usd
CY2022Q4	foxo	Policy Reserves PolicyReserves	18573000	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	651000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	1173000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	14234000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	28700000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	214077	shares
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	161180000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153936000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-172289000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147231000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11103000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6708000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3131000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35408000	usd
CY2023Q3	us-gaap	Revenues Revenues	10000	usd
CY2022Q3	us-gaap	Revenues Revenues	14000	usd
	us-gaap	Revenues Revenues	35000	usd
	us-gaap	Revenues Revenues	93000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	70000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	70000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-60000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	14000	usd
	us-gaap	Gross Profit GrossProfit	-35000	usd
	us-gaap	Gross Profit GrossProfit	93000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	283000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	558000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	925000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2160000	usd
CY2023Q3	foxo	Management Contingent Share Plans ManagementContingentSharePlans	-1553000	usd
	foxo	Management Contingent Share Plans ManagementContingentSharePlans	-141000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2633000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4717000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8269000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15052000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17239000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3447000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	8827000	usd
	us-gaap	Operating Expenses OperatingExpenses	18469000	usd
	us-gaap	Operating Expenses OperatingExpenses	19399000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3507000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8813000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18504000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19306000	usd
CY2022Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-3697000	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-28180000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-36000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	211000	usd
	foxo	Conversion Of Bridge Loans ConversionOfBridgeLoans	88975000	usd
	foxo	Conversion Of Existing Class A Common Stock ConversionOfExistingClassACommonStock	1000	usd
	foxo	Reverse Recapitalization ReverseRecapitalization	19678000	usd
	foxo	Equitybased Compensation EquitybasedCompensation	330000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1349000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-244000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1349000	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1284000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1284000	usd
CY2022Q3	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative	-27378000	usd
	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative	-27378000	usd
	foxo	Loss From Pik Note Amendment And2022 Debenture Release LossFromPIKNoteAmendmentAnd2022DebentureRelease	3521000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	148000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	424000	usd
	us-gaap	Interest Expense InterestExpense	865000	usd
	us-gaap	Interest Expense InterestExpense	1250000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-41000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-779000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-883000	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-153000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-32213000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4088000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-57626000	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3660000	usd
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-41026000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-22592000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-76932000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3660000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-41026000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22592000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76932000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2466000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3660000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-41026000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25058000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76932000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-54002000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	211000	usd
CY2022Q3	foxo	Conversion Of Bridge Loans ConversionOfBridgeLoans	88975000	usd
CY2022Q3	foxo	Conversion Of Existing Class A Common Stock ConversionOfExistingClassACommonStock	1000	usd
CY2022Q3	foxo	Reverse Recapitalization ReverseRecapitalization	19678000	usd
CY2022Q3	foxo	Equitybased Compensation EquitybasedCompensation	330000	usd
CY2022Q3	foxo	Cantor Commitment Fee CantorCommitmentFee	1600000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15767000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-25220000	usd
	foxo	Stock Issued During Period Value Lease Contributions StockIssuedDuringPeriodValueLeaseContributions	225000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	717000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	507000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3000	usd
	foxo	Increase Decrease In Cloud Computing Arrangements IncreaseDecreaseInCloudComputingArrangements	1941000	usd
	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	18573000	usd
	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	709000	usd
	foxo	Cantor Commitment Fee CantorCommitmentFee	1600000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15767000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-7030000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3660000	usd
CY2023Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-1447000	usd
CY2023Q3	foxo	Private Placements Net Of Issuance Costs PrivatePlacementsNetOfIssuanceCosts	444000	usd
CY2023Q3	foxo	Issuance Of Shares To Joseph Gunner IssuanceOfSharesToJosephGunner	221000	usd
CY2023Q3	foxo	Issuance Of Shares To Msk IssuanceOfSharesToMSK	234000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	135000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6708000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25058000	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	226000	usd
	foxo	Debenture Debenture	2181000	usd
	foxo	Paid In Kind Note Amendment PaidInKindNoteAmendment	1339000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2467000	usd
	foxo	Private Placements Net Of Issuance Costs PrivatePlacementsNetOfIssuanceCosts	443000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	135000	usd
	foxo	Issuance Of Shares To Msk IssuanceOfSharesToMSK	234000	usd
	foxo	Issuance Of Shares To Joseph Gunner IssuanceOfSharesToJosephGunner	221000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11103000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22592000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76932000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1251000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	159000	usd
	foxo	Loss From Pik Note Amendment And2022 Debenture Release LossFromPIKNoteAmendmentAnd2022DebentureRelease	3521000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	361000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1002000	usd
	foxo	Cantor Commitment Fee CantorCommitmentFee	1600000	usd
	foxo	Amortization Of Consulting Fees Paid In Common Stock AmortizationOfConsultingFeesPaidInCommonStock	2221000	usd
	foxo	Amortization Of Consulting Fees Paid In Common Stock AmortizationOfConsultingFeesPaidInCommonStock	2954000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2633000	usd
	foxo	Change In Fair Value Of Convertible Debentures ChangeInFairValueOfConvertibleDebentures	28180000	usd
	foxo	Change In Fair Value Of Forward Purchase Agreement Collateral Derivative ChangeInFairValueOfForwardPurchaseAgreementCollateralDerivative	-27378000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-244000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1349000	usd
	foxo	Change In Fair Value Of Forward Purchase Agreement Put Derivative ChangeInFairValueOfForwardPurchaseAgreementPutDerivative	-1284000	usd
	foxo	Conversion Of Accrued Interest ConversionOfAccruedInterest	593000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	419000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	448000	usd
	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments	225000	usd
	foxo	Recognition Of Prepaid Offering Costs Upon Election Of Fair Value Option RecognitionOfPrepaidOfferingCostsUponElectionOfFairValueOption	107000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	100000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	-182000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	1762000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1835000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1002000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1806000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-489000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1891000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	761000	usd
	foxo	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves	18573000	usd
	foxo	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves	709000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6165000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19232000	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	108000	usd
	us-gaap	Payments For Software PaymentsForSoftware	1622000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1730000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	28000000	usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	507000	usd
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	3458000	usd
	foxo	Reverse Recapitalization Proceeds ReverseRecapitalizationProceeds	23226000	usd
	foxo	Forward Purchase Agreement Escrow ForwardPurchaseAgreementEscrow	-29135000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	484000	usd
	foxo	Forward Purchase Agreement Collateral Release To Meteora ForwardPurchaseAgreementCollateralReleaseToMeteora	733000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	744000	usd
	foxo	Related Party Promissory Note RelatedPartyPromissoryNote	247000	usd
	foxo	Related Party Promissory Note RelatedPartyPromissoryNote	-1160000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	299000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	539000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	692000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24560000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5473000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3598000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6856000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10454000	usd
	foxo	Debenture Release DebentureRelease	2181000	usd
	foxo	Pik Note Amendment PIKNoteAmendment	1339000	usd
	foxo	Exchange Offer ExchangeOffer	2466000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	88382000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	21854000	usd
	foxo	Accrued Internal Use Softwares AccruedInternalUseSoftwares	239000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.35pt; text-align: justify; text-indent: -45.35pt"><b><span style="text-decoration:underline">Note 1 DESCRIPTION OF BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOXO Technologies Inc. (“FOXO” or the “Company”), formerly known as Delwinds Insurance Acquisition Corp. (“Delwinds”), a Delaware corporation, was originally formed in April 2020 as a publicly traded special purpose company for the purpose of effecting a merger, capital stock exchange, asset acquisition, reorganization, or similar business combination involving one or more businesses. FOXO is a leader in commercializing epigenetic biomarker technology to support groundbreaking scientific research and disruptive next-generation business initiatives. The Company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness and aging. On October 29<sup>th</sup>, 2023 the Company entered into a Letter Agreement with KR8 AI Inc. to develop a Direct to Consumer app (iOS and Android) combining its AI Machine Learning technology to provide a commercial application of Foxo’s epigenetic biomarker technology as a subscription consumer engagement platform. <span>The Letter Agreement limits the distribution of any such apps to consumers in North America. The Letter Agreement provides that KR8 will grant the Company a non-provisional exclusive License with a perpetual term upon the parties’ signing of a definitive license agreement.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company manages and reports results of operations for the Company’s epigenetic biomarker technology business operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Business Combination</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 24, 2022, Delwinds entered into a definitive Agreement and Plan of Merger, dated as of February 24, 2022, as amended on April 26, 2022, July 6, 2022 and August 12, 2022 (the “Merger Agreement”), with FOXO Technologies Inc., now known as FOXO Technologies Operating Company (“FOXO Technologies Operating Company” or “Legacy FOXO”), DWIN Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Delwinds (“Merger Sub”), and DIAC Sponsor LLC (the “Sponsor”), in its capacity as the representative of the stockholders of Delwinds from and after the closing (the “Closing”) of the transactions contemplated by the Merger Agreement (collectively, the “Business Combination”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Business Combination was approved by Delwinds’ stockholders on September 14, 2022 and closed on September 15, 2022 (the “Closing Date”) whereby Merger Sub merged into FOXO Technologies Operating Company, with FOXO Technologies Operating Company surviving the merger as a wholly owned subsidiary of the Company (the “Combined Company”), and with FOXO Technologies Operating Company security holders becoming security holders of the Combined Company. Immediately upon the Closing, the name of Delwinds was changed to FOXO Technologies Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the Closing, FOXO is a holding company whose wholly-owned subsidiary, FOXO Technologies Operating Company, conducts all of the core business operations. FOXO Technologies Operating Company maintains its two wholly-owned subsidiaries, FOXO Labs Inc. and FOXO Life, LLC. FOXO Labs maintains a wholly-owned subsidiary, Scientific Testing Partners, LLC, while FOXO Life Insurance Company was a wholly-owned subsidiary of FOXO Life, LLC. See Note 10 for more information on FOXO Life Insurance Company. References to “FOXO” and the “Company” in these condensed consolidated financial statements refer to FOXO Technologies Operating Company and its wholly-owned subsidiaries prior to the Closing and FOXO Technologies Inc. following the Closing.</p>
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3660000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22592000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-172289000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6165000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42000	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	28000000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	28000000	usd
CY2023Q3	us-gaap	Other Partners Capital OtherPartnersCapital	300000000	usd
CY2022Q3	foxo	Percentage Of Issued Investors PercentageOfIssuedInvestors	0.15	pure
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3457500000	usd
	foxo	Percentage Of Outstanding Principal Balance PercentageOfOutstandingPrincipalBalance	1.30	pure
CY2023Q3	foxo	Longevity Pipeline LongevityPipeline	592000	usd
CY2022Q4	foxo	Longevity Pipeline LongevityPipeline	592000	usd
CY2023Q3	foxo	Underwriting Api UnderwritingAPI	840000	usd
CY2022Q4	foxo	Underwriting Api UnderwritingAPI	840000	usd
CY2023Q3	foxo	Longevity Api LongevityAPI	717000	usd
CY2022Q4	foxo	Longevity Api LongevityAPI	717000	usd
CY2023Q3	foxo	Indefinite Accumulated Amortization And Impairment IndefiniteAccumulatedAmortizationAndImpairment	1721000	usd
CY2022Q4	foxo	Indefinite Accumulated Amortization And Impairment IndefiniteAccumulatedAmortizationAndImpairment	106000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	428000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2043000	usd
CY2023Q3	foxo	Digital Insurance Platform DigitalInsurancePlatform	2966000	usd
CY2022Q4	foxo	Digital Insurance Platform DigitalInsurancePlatform	2966000	usd
CY2023Q3	foxo	Finite Accumulated Amortization And Impairment FiniteAccumulatedAmortizationAndImpairment	2966000	usd
CY2022Q4	foxo	Finite Accumulated Amortization And Impairment FiniteAccumulatedAmortizationAndImpairment	741000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2225000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1208000	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1425000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2633000	usd
CY2022Q3	foxo	Net Proceeds NetProceeds	2918000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	540000	usd
	foxo	Interest Rate InterestRate	1150
	foxo	Consideration Amount Transferred ConsiderationAmountTransferred	1339000	usd
CY2023Q3	us-gaap	Percentage Of Unamortized Film Costs PercentageOfUnamortizedFilmCosts	0.10	pure
	us-gaap	Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1 DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1	1596000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	256000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1339000	usd
	foxo	Percentage Of Outstanding Principal Balance PercentageOfOutstandingPrincipalBalance	1.30	pure
CY2023Q3	foxo	Senior Paid In Kind Notes SeniorPaidInKindNotes	4006000	usd
CY2023Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	145000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	420000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	448000	usd
CY2022Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	593000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1627000	usd
	foxo	Convertible Debentures Issued Percentage ConvertibleDebenturesIssuedPercentage	0.125	pure
CY2022Q3	foxo	Related Party Holders RelatedPartyHolders	181000	usd
	foxo	Related Party Holders RelatedPartyHolders	508000	usd
CY2023Q3	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	247000	usd
CY2022Q2	foxo	Exchange Fees1 ExchangeFees1	1425000	usd
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	87126	shares
CY2023Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	0	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	2676000	usd
CY2022Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	2081000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	3568000	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
	foxo	Warrants Description WarrantsDescription	●in whole and not in part; ●at a price of $0.10 per warrant; ●upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable; and ●if, and only if, the reported last sale price of the Company’s Class A Common Stock equals or exceeds $180.00 per share for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.
CY2023Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	62.1
CY2023Q2	foxo	Warrants Shares Received WarrantsSharesReceived	48.3	shares
CY2023Q3	foxo	Warrants Of Aggregate Shares WarrantsOfAggregateShares	164751	shares
	us-gaap	Dividend Income Operating Paid In Cash DividendIncomeOperatingPaidInCash	2466	usd
CY2023Q3	foxo	Warrants Remain Outstanding WarrantsRemainOutstanding	25868	usd
CY2023Q3	foxo	Percentage Of Discount Convertible Debentures PercentageOfDiscountConvertibleDebentures	0.10	pure
	us-gaap	Investment Company Redemption Fee Per Share InvestmentCompanyRedemptionFeePerShare	0.067
CY2023Q3	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	1	usd
	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	2181	usd
	foxo	Aggregate Gross Proceeds AggregateGrossProceeds	450	usd
	foxo	Other Offering Expenses OtherOfferingExpenses	260	usd
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	69668	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3660000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-41026000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22592000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76932000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2466000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3660000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-41026000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25058000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76932000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	1037873	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	1037873	shares
CY2023Q3	foxo	Assumed Warrants AssumedWarrants	25868	shares
CY2022Q3	foxo	Assumed Warrants AssumedWarrants	190619	shares
CY2023Q3	foxo	Assumed Option Shares AssumedOptionShares	215094	shares
CY2022Q3	foxo	Assumed Option Shares AssumedOptionShares	296579	shares
CY2023Q3	foxo	Total Antidilutive Shares TotalAntidilutiveShares	1278835	shares
CY2022Q3	foxo	Total Antidilutive Shares TotalAntidilutiveShares	1525071	shares
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	67000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	311000	usd
CY2023Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	5002000	usd
CY2023Q1	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	51000	usd
CY2023Q1	us-gaap	Ceded Premiums Earned CededPremiumsEarned	251000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	4751000	usd
CY2023Q3	us-gaap	Revenues Revenues	10000	usd
CY2022Q3	us-gaap	Revenues Revenues	14000	usd
CY2023Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	3660000	usd
CY2022Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	41026000	usd
	us-gaap	Revenues Revenues	35000	usd
	us-gaap	Revenues Revenues	93000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	22592000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	76932000	usd
CY2023Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	5000	usd
CY2022Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	74000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1251000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	159000	usd
	foxo	Purchase Units PurchaseUnits	10000	shares
	foxo	Supply Commitment Remaining SupplyCommitmentRemaining	3000	shares
CY2023Q3	us-gaap	Purchase Obligation PurchaseObligation	14000	usd
	foxo	Outstanding Balance Percentage OutstandingBalancePercentage	0.125	pure
	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	6207000	usd
	foxo	Percentage Of Gross Proceeds PercentageOfGrossProceeds	0.25	pure
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	955000	usd
CY2023Q3	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	620000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	9130000	usd
	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	2300000	usd
CY2022	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	0	usd
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	25000	usd
CY2023Q3	us-gaap	Trading Liabilities Fair Value Disclosure TradingLiabilitiesFairValueDisclosure	1000000	usd
CY2023Q3	foxo	Trading Value Percentage TradingValuePercentage	3	pure
	foxo	Common Stock Issued Percentage CommonStockIssuedPercentage	0.0999	pure
	foxo	Common Stock Outstanding Percentage CommonStockOutstandingPercentage	0.0999	pure
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	200000	usd
CY2023Q3	us-gaap	Share Price SharePrice	1
	foxo	Percentage Of Exceed Outstanding PercentageOfExceedOutstanding	0.1999	pure
	foxo	Percentage Of Warrant Coverage PercentageOfWarrantCoverage	0.07	pure
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7000	shares
	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	1.324
	foxo	Percentage Of Exercise Price PercentageOfExercisePrice	1.10	pure
	foxo	Percentage Of Subcriber Revenue PercentageOfSubcriberRevenue	0.15	pure
CY2023Q3	foxo	Prepaid Consulting Fees PrepaidConsultingFees		usd
CY2023Q3	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables		usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q3	foxo	Senior Paid In Kind Notes Non Current SeniorPaidInKindNotesNonCurrent		usd
CY2023Q3	foxo	Policy Reserves PolicyReserves		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q3	foxo	Management Contingent Share Plans ManagementContingentSharePlans		usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023Q3	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative		usd
	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative		usd
CY2023Q3	foxo	Loss From Pik Note Amendment And2022 Debenture Release LossFromPIKNoteAmendmentAnd2022DebentureRelease		usd
CY2022Q3	foxo	Loss From Pik Note Amendment And2022 Debenture Release LossFromPIKNoteAmendmentAnd2022DebentureRelease		usd
	foxo	Loss From Pik Note Amendment And2022 Debenture Release LossFromPIKNoteAmendmentAnd2022DebentureRelease		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022Q3	foxo	Conversion Of Class B Common Stock ConversionOfClassBCommonStock		usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	foxo	Conversion Of Class B Common Stock ConversionOfClassBCommonStock		usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod		usd
	foxo	Loss From Pik Note Amendment And2022 Debenture Release LossFromPIKNoteAmendmentAnd2022DebentureRelease		usd
	foxo	Cantor Commitment Fee CantorCommitmentFee		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	foxo	Change In Fair Value Of Convertible Debentures ChangeInFairValueOfConvertibleDebentures		usd
	foxo	Change In Fair Value Of Forward Purchase Agreement Collateral Derivative ChangeInFairValueOfForwardPurchaseAgreementCollateralDerivative		usd
	foxo	Change In Fair Value Of Forward Purchase Agreement Put Derivative ChangeInFairValueOfForwardPurchaseAgreementPutDerivative		usd
	foxo	Conversion Of Accrued Interest ConversionOfAccruedInterest		usd
	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments		usd
	foxo	Recognition Of Prepaid Offering Costs Upon Election Of Fair Value Option RecognitionOfPrepaidOfferingCostsUponElectionOfFairValueOption		usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	foxo	Increase Decrease In Cloud Computing Arrangements IncreaseDecreaseInCloudComputingArrangements		usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
	us-gaap	Payments For Software PaymentsForSoftware		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		usd
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt		usd
	foxo	Reverse Recapitalization Proceeds ReverseRecapitalizationProceeds		usd
	foxo	Forward Purchase Agreement Escrow ForwardPurchaseAgreementEscrow		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	foxo	Forward Purchase Agreement Collateral Release To Meteora ForwardPurchaseAgreementCollateralReleaseToMeteora		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	foxo	Debenture Release DebentureRelease		usd
	foxo	Pik Note Amendment PIKNoteAmendment		usd
	foxo	Exchange Offer ExchangeOffer		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	foxo	Accrued Internal Use Softwares AccruedInternalUseSoftwares		usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-25058000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-41026000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-76932000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3660000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001812360

Files In Submission

Name	View Source	Status
foxo-20230930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
0001213900-24-004925-index-headers.html	Edgar Link	pending
0001213900-24-004925-index.html	Edgar Link	pending
0001213900-24-004925.txt	Edgar Link	pending
0001213900-24-004925-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_foxotech.htm	Edgar Link	pending
f10q0923ex31-2_foxotech.htm	Edgar Link	pending
f10q0923ex32-1_foxotech.htm	Edgar Link	pending
f10q0923_foxotech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
foxo-20230930.xsd	Edgar Link	pending
foxo-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
foxo-20230930_def.xml	Edgar Link	unprocessable
foxo-20230930_lab.xml	Edgar Link	unprocessable
f10q0923_foxotech_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

2024 Q1 Form 10-Q Financial Statement

#000121390024004925 Filed on January 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO FOXO TECHNOLOGIES INC. Stock $foxo

2024 Q1 Form 10-Q Financial Statement

#000121390024004925 Filed on January 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo